rs2307447

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The c.1637C>T (p.Arg546Cys) variant in POLG has been reported with an allele frequency in the African American population at 1.88% in gnomAD. (BA1). In summary, this variant meets criteria to be classified as benign for primary mitochondrial disease inherited in a recessive manner. ntDNA Mitochondrial ACMG-AMP Criteria for POLG applied: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA292876/MONDO:0044970/014

Frequency

Genomes: 𝑓 0.0049 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00058 ( 6 hom. )

Consequence

POLG
NM_002693.3 missense

Scores

7
11

Clinical Significance

Benign reviewed by expert panel B:8

Conservation

PhyloP100: 2.85
Variant links:
Genes affected
POLG (HGNC:9179): (DNA polymerase gamma, catalytic subunit) Mitochondrial DNA polymerase is heterotrimeric, consisting of a homodimer of accessory subunits plus a catalytic subunit. The protein encoded by this gene is the catalytic subunit of mitochondrial DNA polymerase. The encoded protein contains a polyglutamine tract near its N-terminus that may be polymorphic. Defects in this gene are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions 1 (PEOA1), sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO), Alpers-Huttenlocher syndrome (AHS), and mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BA1

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POLGNM_002693.3 linkuse as main transcriptc.1636C>T p.Arg546Cys missense_variant 9/23 ENST00000268124.11
POLGARFNM_001406557.1 linkuse as main transcriptc.*908C>T 3_prime_UTR_variant 9/23
POLGNM_001126131.2 linkuse as main transcriptc.1636C>T p.Arg546Cys missense_variant 9/23

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POLGENST00000268124.11 linkuse as main transcriptc.1636C>T p.Arg546Cys missense_variant 9/231 NM_002693.3 P1

Frequencies

GnomAD3 genomes
AF:
0.00496
AC:
754
AN:
152154
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00153
AC:
385
AN:
251354
Hom.:
2
AF XY:
0.00118
AC XY:
161
AN XY:
135874
show subpopulations
Gnomad AFR exome
AF:
0.0188
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000158
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000578
AC:
845
AN:
1461840
Hom.:
6
Cov.:
33
AF XY:
0.000481
AC XY:
350
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.0190
Gnomad4 AMR exome
AF:
0.00139
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000220
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.0000378
Gnomad4 OTH exome
AF:
0.00134
GnomAD4 genome
AF:
0.00494
AC:
752
AN:
152272
Hom.:
7
Cov.:
32
AF XY:
0.00475
AC XY:
354
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.0168
Gnomad4 AMR
AF:
0.00255
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00236
Alfa
AF:
0.000742
Hom.:
2
Bravo
AF:
0.00578
ESP6500AA
AF:
0.0170
AC:
75
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00170
AC:
206
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submittercurationSIB Swiss Institute of BioinformaticsMay 31, 2018This variant is interpreted as a Benign - Stand Alone. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >1% in African population in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Likely benign, criteria provided, single submitterclinical testingAthena DiagnosticsNov 17, 2020- -
Progressive sclerosing poliodystrophy Benign:2
Benign, criteria provided, single submitterclinical testingWong Mito Lab, Molecular and Human Genetics, Baylor College of MedicineOct 01, 2018The NM_002693.2:c.1636C>T (NP_002684.1:p.Arg546Cys) [GRCH38: NC_000015.10:g.89326688G>A] variant in POLG gene is interpretated to be a Benign based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID:19629138 . This variant meets the following evidence codes reported in the ACMG-guideline. BS1:The minor allele frequency of this allele is high for Mitochondrial DNA depletion syndrome 4A (Alpers type). BS2:Observation of the variant in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 4A (Alpers type). BP4:Computational evidence/predictors indicate no impact on the POLG structure, function, or protein-protein interaction. Based on the evidence criteria codes applied, the variant is suggested to be Benign. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 30, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 22, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Mitochondrial disease Benign:1
Benign, reviewed by expert panelcurationClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGenMay 07, 2021The c.1637C>T (p.Arg546Cys) variant in POLG has been reported with an allele frequency in the African American population at 1.88% in gnomAD. (BA1). In summary, this variant meets criteria to be classified as benign for primary mitochondrial disease inherited in a recessive manner. ntDNA Mitochondrial ACMG-AMP Criteria for POLG applied: BA1. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJul 30, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.42
T;T
Eigen
Benign
0.16
Eigen_PC
Benign
0.17
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.87
.;D
MetaRNN
Benign
0.0070
T;T
MetaSVM
Uncertain
0.14
D
MutationAssessor
Benign
2.0
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-1.8
N;N
REVEL
Uncertain
0.41
Sift
Benign
0.030
D;D
Sift4G
Uncertain
0.053
T;T
Polyphen
0.99
D;D
Vest4
0.50
MVP
0.87
MPC
0.49
ClinPred
0.037
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.14
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2307447; hg19: chr15-89869919; COSMIC: COSV51522658; COSMIC: COSV51522658; API